Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Systemic Effects of Metastatic Cancer

WEBINAR

Only

Systemic Effects of Metastatic Cancer

Wednesday, October 21 - Thursday, October 22, 2020 EDT

Webinar

Presented By

The New York Academy of Sciences

 

Metastatic cancer exerts systemic effects on the entire body. Its influence on the immune system and distant organs leads to pre-metastatic niche formation and metastasis, alongside vascular and metabolic changes, lung failure, loss of bone density, muscle wasting and cachexia, as well as neuropathies. These effects not only promote tumor progression, but they are deleterious to patient quality of life and survival.

The myriad effects induced by metastasis present several new therapeutic targets, and successful blockade of cancer’s systemic influence may have several beneficial outcomes: it could interfere with disease progression, and it could enhance patient quality of life and longevity. In addition, systemic alterations may serve as sentinels of cancer spread, and therefore provide a novel panel of biomarkers for early detection of metastasis. This symposium aims to deepen our understanding of the complex results of systemic metastatic disease, and inspire the development of effective therapeutic strategies to prevent and treat the systemic outcomes of cancer metastasis.

Call for Abstracts

Abstract submissions are invited for a poster session and short talks. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Thursday, September 10, 2020.

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$130
Nonmember Corporate, Other
$170
Nonmember Not for Profit
$130
Nonmember Student, Undergrad, Grad, Fellow
$90
Member Student, Post-Doc, Fellow
$30
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
37
days
left

Scientific Organizing Committee

Swarnali Acharyya, PhD
Swarnali Acharyya, PhD

Columbia University

David Lyden, MD, PhD
David Lyden, MD, PhD

Weill Cornell Medicine

George Miller
George Miller, MD

NYU School of Medicine

Alexia Zaromytidou, PhD
Alexia Zaromytidou, PhD

Nature Cancer

Sonya Dougal
Sonya Dougal, PhD

New York Academy of Sciences

Kari Fischer, PhD
Kari Fischer, PhD

New York Academy of Sciences

Keynote Speakers

Kornelia Polyak
Kornelia Polyak, MD, PhD

Dana-Farber Cancer Institute

Gregg Semenza
Gregg Semenza, MD, PhD

Johns Hopkins University School of Medicine

Speakers

Swarnali Acharyya, PhD
Swarnali Acharyya, PhD

Columbia University

Michael Angelo
Michael Angelo, MD, PhD

Stanford University

Susan Bullman, PhD
Susan Bullman, PhD

Fred Hutchinson Cancer Research Center

Brunhilde Felding, PhD
Brunhilde Felding, PhD

Scripps Research

Silvia Formenti
Silvia Formenti, MD

Weill Cornell Medicine

Paul Frenette
Paul Frenette, MD

Albert Einstein College of Medicine

Cyrus Ghajar
Cyrus Ghajar, PhD

Fred Hutchinson Cancer Research Center

Tim Greten
Tim Greten, MD

National Cancer Institute

Theresa Guise
Theresa Guise, MD

Indiana University School of Medicine

Lee Jones
Lee Jones, PhD

Memorial Sloan Kettering Cancer Center

Rosandra N. Kaplan, MD
Rosandra N. Kaplan, MD

National Cancer Institute

George Miller
George Miller, MD

NYU School of Medicine

Andy J. Minn, MD, PhD
Andy J. Minn, MD, PhD

University of Pennsylvania

Carla Prado, PhD, RD
Carla Prado, PhD, RD

University of Alberta

Patricia Steeg
Patricia Steeg, PhD

National Cancer Institute

Matthew Vander Heiden
Matthew Vander Heiden, MD, PhD

Massachusetts Institute of Technology

Program Supporters